An interventional study of Speech Therapy and Proprioceptive treatment in Developmental Dyslexia, sponsored by Scalab CNRS 9193. Status unknown at 1 site in France. Open to participants aged 9 Years to 14 Years. Per ClinicalTrials.gov, last updated 2020-03-17.
Sponsored by Scalab CNRS 9193 · Not applicable, Interventional, and Treatment
To show the interest of the association of proprioceptive and orthophonic care of dyslexic children. The assumption is that proprioceptive support by correcting a centrally located spatial localization instability restores the ability to automate.
It allows a gain of effectiveness of the orthophonic remediation of the reading of dyslexic children.
Interventional comparative study over 9 months, of three modes of care: Speech-language, or proprioceptive, or combined (speech therapy or proprioceptive)
Exclusion Criteria:
Speech therapy adapted to the child,
Other: Speech Therapy
Association of speech therapy and proprioceptive treatment, adapted to the child.
Other: Speech Therapy · Other: Proprioceptive treatment
Speech therapy adapted to the child, at least 25 sessions over 9 months.
Also known as: Orthophonic treatment
Proprioceptive treatment adapted to the child. This treatment aims to stabilize a central reference instability revealed to Maddox Postural by the use of neurosensory decoys:: * Proprioceptive stimulation of oculomotor muscles (active prisms). * Oral somatosensory stimulation (ALPH). * Proprioceptive antigravity stimulation (proprioceptive sole). * Proprioceptive reprogramming exercise. Following the teaching of the University Diploma: Perception-Action, Learning Disorders (University of Bourgogne, France)
Change from baseline C index ( Alouatte-R test) at 9 months
Number of correctly read words (standard deviation)
Time frame: Baseline, at nine months
Change from baseline TL index ( Alouatte-R test) at 9 months
Reading time in second (TL) (standard deviation)
Time frame: Baseline, at nine months
Change from baseline M index ( Alouatte-R test) at 9 months
Number of words read (M)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline E index ( Alouatte-R test) at 9 months
Number of errors (E)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline CM index ( Alouatte-R test) at 9 months
Precision index (CM)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline CTL index ( Alouatte-R test) at 9 months
Speed index (CTL)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline Regular ODEDYS test at 9 months
Regular words reading, Screening tools for dyslexia (ODEDYS)(standard deviation)
Time frame: Baseline, at nine months
Change from baseline Irregular ODEDYS test at 9 months
Irregular words reading (standard deviation)
Time frame: Baseline, at nine months
change from baseline Pseudo-words ODEDYS test at 9 months
Pseudo-words reading (standard deviation)
Time frame: Baseline, at nine months
Change from base line DFF VOG at 9 months
Duration of first fixation (DFF), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Change from baseline DL VOG at 9 months
Duration of look (DL), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Change from baseline TFT VOG at 9 months
Total fixation time (TFT), of the measured reading in Video Oculography (VOG),
Time frame: Baseline, at nine months
Observation of the evolution of the shape of maxwells spots from baseline at 9 months
From the shape of Maxwell's tasks to the fovea-scope
Time frame: Baseline, at nine months
Vertical orthophoria
Comparison of the evolution of reading tests, taking into account the presence or absence of localization instability, whatever the treatment groups.
Time frame: Baseline, at nine months
Plan to share: No
This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.